Bibliography Updates May 2020
Rules-Based Medicine's, a Q2 Solutions Company (formerly Myriad RBM) biomarker testing services and TruCulture product have been cited in over 1000 pe...

Prognostic Lung Fibrosis Consortium (PROLIFIC) /Myriad RBM Collaborate on Pulmonary Fibrosis Biomarker Panel
PROLIFIC - Idiopathic Pulmonary Fibrosis Celgene, a wholly owned subsidiary of Bristol-Myers Squibb Company, created a consortium called PROLIFIC (Pr...